CareLit · DOI-Nachweis · Pneumologie
Second line chemotherapy exposure in a German Cancer Society certified lung cancer center: single center experience of 3 years and relevance for maintenance therapy
DOI 10.1055/s-0034-1367777
Bibliografische Angaben
Nachweis in CareLit
Autor:innenF Griesinger, R Prenzel, V Halbfass, D Scriba, A Lüers, KC Willborn
ZeitschriftPneumologie
Ausgabe02/2014
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Introduction: One of the strongest rationale for maintenance therapy in NSCLC is the fact that exposure to 2nd line therapy is only 40 – 60% in clinical trials in specialized treatment centers. Even with follow-up intervals of 6 weeks, the 2nd line treatment rate does not seem to increase in clinical trials. One of the main arguments for maintenance treatment is that 2nd line exposure in international clinical trial…
Zitieren
Zitierempfehlung
F Griesinger, R Prenzel, V Halbfass, D Scriba, A Lüers, KC Willborn (2014) Second line chemotherapy exposure in a German Cancer Society certified lung cancer center: single center experience of 3 years and relevance for maintenance therapy. Pneumologie (02). https://doi.org/10.1055/s-0034-1367777
Mit CareLit weiterarbeiten